Prospective Database for Chronic Myelogenous Leukemia
NCT00538447 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2011-12-13
Summary
Prospective Database for Chronic Myelogenous Leukemia
Conditions
- Leukemia, Myeloid, Chronic
Interventions
- OTHER
-
Database
data base for CML
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Naeeem Chaudhri, MD · King Faisal Specialist Hospital & Research Center
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2020-06-30
More Related Trials
-
The Patient Cohort of the National Center for Precision Medicine in Leukemia
NCT05326919 ·Status: RECRUITING
-
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT03509896 ·Status: COMPLETED
-
The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis
NCT02696304 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia
NCT03881826 ·Status: COMPLETED ·Phase: NA
-
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT03128411 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
NCT01150058 ·Status: COMPLETED
-
Study of miRNA-155 in Acute Leukemia
NCT05809050 ·Status: UNKNOWN
-
Understanding Chronic Lymphocytic Leukemia
NCT04028531 ·Status: RECRUITING
-
B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)
NCT02493829 ·Status: UNKNOWN ·Phase: PHASE1
-
Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia
NCT05988047 ·Status: COMPLETED
-
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
NCT01254188 ·Status: COMPLETED ·Phase: PHASE3
-
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
NCT00540956 ·Status: COMPLETED ·Phase: NA
-
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
NCT00899743 ·Status: COMPLETED
-
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735 ·Status: RECRUITING
-
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy
NCT03889951 ·Status: UNKNOWN
-
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
NCT00003861 ·Status: ACTIVE_NOT_RECRUITING
-
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"
NCT00155844 ·Status: UNKNOWN
-
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT01251159 ·Status: COMPLETED
-
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
NCT03197259 ·Status: RECRUITING
-
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
NCT05007860 ·Status: COMPLETED
-
Chronic Kidney Disease Patient in Chronic Myloied Leukemia
NCT06266975 ·Status: NOT_YET_RECRUITING
-
Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
NCT05363488 ·Status: COMPLETED
-
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
NCT04883125 ·Status: COMPLETED ·Phase: PHASE2
-
FT538 in Subjects With Advanced Hematologic Malignancies
NCT04614636 ·Status: TERMINATED ·Phase: PHASE1